BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 33010004)

  • 1. AIP variant causing familial prolactinoma.
    Carty DM; Harte R; Drummond RS; Ward R; Magid K; Collier D; Owens M; Korbonits M
    Pituitary; 2021 Feb; 24(1):48-52. PubMed ID: 33010004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of
    Tuncer FN; Çiftçi Doğanşen S; Serbest E; Tanrıkulu S; Ekici Y; Bilgiç B; Yarman S
    Genet Test Mol Biomarkers; 2018 Dec; 22(12):702-708. PubMed ID: 30461320
    [No Abstract]   [Full Text] [Related]  

  • 3. Germline AIP mutations in apparently sporadic pituitary adenomas: prevalence in a prospective single-center cohort of 443 patients.
    Cazabat L; Bouligand J; Salenave S; Bernier M; Gaillard S; Parker F; Young J; Guiochon-Mantel A; Chanson P
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E663-70. PubMed ID: 22319033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should aip gene screening be recommended in family members of FIPA patients with R16H variant?
    Zatelli MC; Torre ML; Rossi R; Ragonese M; Trimarchi F; degli Uberti E; Cannavò S
    Pituitary; 2013 Jun; 16(2):238-44. PubMed ID: 22915287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for AIP gene mutations in a Han Chinese pituitary adenoma cohort followed by LOH analysis.
    Cai F; Zhang YD; Zhao X; Yang YK; Ma SH; Dai CX; Liu XH; Yao Y; Feng M; Wei JJ; Xing B; Jiao YH; Wei ZQ; Yin ZM; Zhang B; Gu F; Wang RZ
    Eur J Endocrinol; 2013 Dec; 169(6):867-84. PubMed ID: 24050928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant Benefits of AIP Testing and Clinical Screening in Familial Isolated and Young-onset Pituitary Tumors.
    Marques P; Caimari F; Hernández-Ramírez LC; Collier D; Iacovazzo D; Ronaldson A; Magid K; Lim CT; Stals K; Ellard S; Grossman AB; Korbonits M;
    J Clin Endocrinol Metab; 2020 Jun; 105(6):e2247-60. PubMed ID: 31996917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do the aryl hydrocarbon receptor interacting protein variants (Q228K and Q307R) play a role in patients with familial and sporadic hormone-secreting pituitary adenomas?
    Yarman S; Ogret YD; Oguz FS
    Genet Test Mol Biomarkers; 2015 Jul; 19(7):394-8. PubMed ID: 25938168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the aryl hydrocarbon receptor-interacting protein gene in familial and sporadic pituitary adenomas.
    Leontiou CA; Gueorguiev M; van der Spuy J; Quinton R; Lolli F; Hassan S; Chahal HS; Igreja SC; Jordan S; Rowe J; Stolbrink M; Christian HC; Wray J; Bishop-Bailey D; Berney DM; Wass JA; Popovic V; Ribeiro-Oliveira A; Gadelha MR; Monson JP; Akker SA; Davis JR; Clayton RN; Yoshimoto K; Iwata T; Matsuno A; Eguchi K; Musat M; Flanagan D; Peters G; Bolger GB; Chapple JP; Frohman LA; Grossman AB; Korbonits M
    J Clin Endocrinol Metab; 2008 Jun; 93(6):2390-401. PubMed ID: 18381572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
    Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
    Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
    J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic and genotypic features of a large kindred with a germline AIP variant.
    Dal J; Nielsen EH; Klose M; Feldt-Rasmussen U; Andersen M; Vang S; Korbonits M; Jørgensen JOL
    Clin Endocrinol (Oxf); 2020 Aug; 93(2):146-153. PubMed ID: 32324286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Somatostatin analogues increase AIP expression in somatotropinomas, irrespective of Gsp mutations.
    Jaffrain-Rea ML; Rotondi S; Turchi A; Occhi G; Barlier A; Peverelli E; Rostomyan L; Defilles C; Angelini M; Oliva MA; Ceccato F; Maiorani O; Daly AF; Esposito V; Buttarelli F; Figarella-Branger D; Giangaspero F; Spada A; Scaroni C; Alesse E; Beckers A
    Endocr Relat Cancer; 2013 Oct; 20(5):753-66. PubMed ID: 23940012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
    Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
    Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
    Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.